Navigation Links
ARGX-110, a Novel Anti-CD70 Antibody, Meets Translational Development Goals in Dose Escalation Part of Phase Ib Cancer Study
Date:12/17/2013

BREDA, The Netherlands and GHENT, Belgium, December 17, 2013 /PRNewswire/ --

Dose confirmed for Phase Ib safety and efficacy expansion study

arGEN-X announces that the dose-escalation part of a Phase Ib study with its lead antibody ARGX-110 has met its translational development goals: all pre-specified biological activity measures (e.g. target engagement, effector functions, immune-modulation) were met. The study also showed that ARGX-110 has a favourable safety profile and a dose has been selected to advance into the Phase Ib safety and efficacy expansion cohorts, which will start early in 2014 and are expected to report top-line results approximately 12 months later.

ARGX-110 is a first-in-class monoclonal antibody potently blocking CD70 induced tumor proliferation and tumor escape from immune surveillance. In addition, the POTELLIGENT®-enhanced antibody-dependent cellular cytotoxicity (ADCC) of ARGX-110 enables selective destruction of CD70-positive tumor cells. CD70 is overexpressed in the majority of cancer patients tested to date. Expectations of a favourable therapeutic index stem from its virtual absence in healthy tissues.

In the study, 19 patients with CD70-positive cancer were treated with escalating doses of ARGX-110, up to 10 mg/kg. The results show predictable pharmacokinetics across the dose range. No dose-limiting toxicity was identified. For Ahmad Awada, MD PhD, principal investigator of the study at the Jules Bordet Institute (Brussels, Belgium), "these results, at the clinical and immunological levels, open the door to study further the antibody as a single agent and in combination trials with small molecules and other immune checkpoint inhibitors."

Based on these data, arGEN-X will begin enrolment to hematology and solid tumor safety and efficacy expansion cohorts early in 2014 and report top-line r
'/>"/>

SOURCE arGEN-X
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Market for Non-Small-Cell Lung Cancer (NSCLC) Will Grow to $7 Billion in 2022, Fuelled by the Entry of Twelve Novel Agents
2. The Acute Coronary Syndrome 12-Month Posthospital Market Will Double by 2022, Driven by the Uptake of Novel Lipid Modifying Agents
3. Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
4. High Cost of Biologics and Novel Oral Agents to Treat Immune Diseases Limits Patient Access
5. Opportunity Exists in the U.S. for Novel Agents in Crohns Disease and Ulcerative Colitis, Owing to Discontinued Use of Leading Anti-TNF Agents Driven by Efficacy Failures
6. Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
7. Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
8. FLAG Therapeutics and Duquesne University Announce Exclusive Worldwide Licensing Agreement for Novel, Dual-action Targeted Oncology Compounds
9. Increasing Use of Allergans Botox and the Launch of Novel Nontriptan Products Will Be Key Drivers of Migraine Market Growth Through 2022
10. Novel Molecular Assay for Patient Screening Detects S. aureus and Newly Emerging MRSA Strains Available in the United States
11. Unilife Announces Clinical Supply Agreement for Delivery of a Novel Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Women everywhere know how frustrating a vaginal ... they,re often also embarrassing and have a way of ... ( http://ph-defense.com ) is a new, over-the-counter product designed ... product. Odor, discharge, and discomfort or ... In many cases, the cause of such problems can ...
(Date:9/17/2014)... N.J. , Sept. 17, 2014   ... details how to implement GS1 Standards to support ... and enhance patient safety and security in the ... Applying GS1 Standards to U.S. Pharmaceutical Supply Chain ... Security Act , was developed in collaboration ...
(Date:9/17/2014)... MILL VALLEY, Calif. , Sept. 17, ... announced a partnership in the fight against sarcoma. ... Sarcoma Alliance Suzanne Renee Leider Memorial Assistance Fund. ... assistance to reimburse sarcoma patients for expenses directly ... sarcoma specialist. Scientific literature reinforces the importance of ...
Breaking Medicine Technology:New Product from Vireo Systems: pH-D Feminine Health Support 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3
... Inc., the global leader in cold chain visibility ... (IATA) has deemed Sensitech,s full range of temperature ... with the 53rd edition of the IATA Dangerous ... the United Nations.   The size and lithium metal ...
...  Online news publication in-PharmaTechnologist.com ... news in key biopharma manufacturing niches. Using the ... of four microsites - Ingredients , Processing , ... - each of which delivers highly targeted news. ...
Cached Medicine Technology:Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched 2
(Date:9/17/2014)... 2014 The Delta Dental Community Care ... National Children’s Oral Health Foundation: America’s ToothFairy (NCOHF) to ... County Oral Health Zone Program® in California. , The ... a range of local constituent groups and stakeholders in ... tooth decay and its devastating effects on local families. ...
(Date:9/17/2014)... diabetes, quitting smoking, controlling high blood pressure, exercising and ... dementia -- even late in life, according to new ... by Alzheimer,s Disease International, revealed that diabetes can increase ... noted that obesity and an inactive lifestyle are key ... pressure. The researchers suggested that dementia should ...
(Date:9/17/2014)... not properly designed to meet the needs of patients ... families, and major changes to the system are necessary, ... The 21-member committee that wrote the report envisioned ... care and social services and that is high-quality, affordable, ... care planning" for end-of-life by individuals, for improved training ...
(Date:9/17/2014)... most 18-month-olds learn an average of two to five ... how children process information to learn new words as ... study, a University of Missouri researcher has found that ... limit exists as to how many words they can ... their children,s vocabularies and assist speech-language professionals in developing ...
(Date:9/17/2014)... 17, 2014 CarePoint Health became the ... 150 CarePoint Health employees participated in the Ice Bucket ... Association. The event took place on September 9, ... CarePoint Health donated $100 to the ALS Association for ... total of approximately $15,000. The Ice Bucket Challenge was ...
Breaking Medicine News(10 mins):Health News:Delta Dental Community Care Foundation Donation to America's ToothFairy Helps Deliver Critical Services 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 2Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 4Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 5Health News:Babies learn words differently as they age, researcher finds 2Health News:CarePoint Health Accepts the Ice Bucket Challenge 2Health News:CarePoint Health Accepts the Ice Bucket Challenge 3
... reveals that virgin olive oil is the best among vegetable ... the Annals of Internal Medicine.// It says heart disease risk ... first pressing of olives gives virgin olive oil. Refined oil ... polyphenols than the latter. ,The study was conducted ...
... intelligent ways to conquer the ubiquitous problem of the bulge, ... protein rich diet vis a vis carbohydrate or fat laden ... of fewer calories that wards off obesity. ... the quantity of peptide YY (PYY), a hormone that actually ...
... situation can play an important role in inspiring memory. ... conducting a more in-depth research// on the formation of ... very anticipation of a fearful situation can stir up ... event has occurred. ,The researchers explained that ...
... women patients who wish to preserve their modesty for religious ... in Lancashire have asked a Calderdale firm is to make ... patients for protection of their religious beliefs. ... considered the first of its kind to be introduced in ...
... have a decreased risk of developing diabetes, according to ... The study found that// only 8 percent of the ... percent of those on older drugs. ,The ... Norvasc and Coversyl with a beta-blocker and a diuretic. ...
... the American Medical Association finds that despite the existing ... training, or// residency includes shifts that involve working long ... Medical Education (ACGME) say that they must be allowed ... Medical School, and colleagues said that interns reported working ...
Cached Medicine News:Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Burka Style Inter-faith Gowns For Muslim Patients In UK 2
Two-channel, Berman design. Semirigid, nontoxic polyethylene. Individually packaged, 48 per case. Latex Free....
Black elastomer. Smooth finish. Non-Sterile....
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Includes one of each size airway. Plastic. Color coded for size. Single use. Non-Sterile....
Medicine Products: